Schottland. Guidance on contingency planning for people who use drugs and COVID-19 Guidance has been produced on contingency planning for people who use drugs and COVID-19 and has been shared with all Alcohol and Drug Partnerships and all drug serv…

USA. FAQs: Provision of methadone and buprenorphine SAMHSA, USA, Updated 21.04.2020) https://www.samhsa.gov/sites/default/files/faqs-for-oud-prescribing-and-dispensing.pdf

UNODC. Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic  A contribution to the health security of countries and communities.(UNODC, April 2020) https://www.unodc.org…

Preventing COVID-19 outbreak in prisons: a challenging but essential task for authorities Today, WHO/Europe has published interim guidance on how to deal with the coronavirus disease (COVID-19) in prisons and other places of detention, entitled “Pr…

Kanada - British Columbia. COVID-19: Information for Opioidagonist Treatment Presribers and Pharmacists March 17, 2020  BCCSU – British Columbia Centre on Substance Use, 17.032020 https://www.bccsu.ca/wp-content/uploads/2020/03/COVID-19-Bulle…

Kanada - British Columbia. RISK MITIGATION IN THE CONTEXT OF DUAL PUBLIC HEALTH EMERGENCIES – Interim Clinical Guidance BCCSU – British Columbia Centre on Substance Use, März 2020, Version 1.2  https://www.bccsu.ca/wp-content/uploads/202…